Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Virology ; 512: 48-55, 2017 12.
Article in English | MEDLINE | ID: mdl-28915405

ABSTRACT

Despite drug advances for Hepatitis C virus (HCV), re-infections remain prevalent in high-risk populations. Unfortunately, the role of preexisting viral immunity and how it modulates re-infection is unclear. GBV-B infection of common marmosets is a useful model to study tissue immune responses in hepacivirus infections, and in this study we re-challenged 4 animals after clearance of primary viremia. Although only low-to-absent viremia was observed following re-challenge, GBV-B viral RNA was detectable in liver, confirming re-infection. Microscopic hepatic lesions indicated severe-to-mild lymphocyte infiltration and fibrosis in 3 out of 4 animals. Further, GBV-B-specific T cells were elevated in animals with moderate-to-severe hepatopathology, and up to 3-fold increases in myeloid dendritic and activated natural killer cells were observed after infection. Our data indicate that occult hepacivirus re-infections occur and that new liver pathology is possible even in the presence of anti-hepacivirus T cells and in the absence of high viremia.


Subject(s)
Flaviviridae Infections/immunology , GB virus B/physiology , Hepatitis, Viral, Animal/immunology , Animals , Callithrix , Flaviviridae Infections/pathology , Hepatitis, Viral, Animal/pathology , Immunity, Innate/physiology , Liver/pathology , Liver/virology , T-Lymphocytes/physiology , Viral Load , Viremia
2.
Microbiol Immunol ; 60(1): 26-34, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26634303

ABSTRACT

The development of effective hepatitis C virus (HCV) vaccines is essential for the prevention of further HCV dissemination, especially in developing countries. Therefore the aim of this study is to establish a feasible and immunocompetent surrogate animal model of HCV infection that will help in evaluation of the protective efficacy of newly developing HCV vaccine candidates. To circumvent the narrow host range of HCV, an HCV genotype 1b-based chimeric clone carrying E1, E2 and p6 regions from GB virus B (GBV-B), which is closely related to HCV, was generated. The chimera between HCV and GBV-B, named HCV/G, replicated more efficiently as compared with the HCV clone in primary marmoset hepatocytes. Furthermore, it was found that the chimera persistently replicated in a tamarin for more than 2 years after intrahepatic inoculation of the chimeric RNA. Although relatively low (<200 copies/mL), the viral RNA loads in plasma were detectable intermittently during the observation period. Of note, the chimeric RNA was found in the pellet fraction obtained by ultracentrifugation of the plasma at 73 weeks, indicating production of the chimeric virus. Our results will help establish a novel non-human primate model for HCV infection on the basis of the HCV/G chimera in the major framework of the HCV genome.


Subject(s)
GB virus B/physiology , Hepatitis, Viral, Animal/virology , Monkey Diseases/virology , Platyrrhini/virology , Virus Replication/genetics , Amino Acid Sequence , Animals , Base Sequence , Chimera/genetics , Chimera/virology , Disease Models, Animal , Flaviviridae Infections/virology , GB virus B/genetics , GB virus B/immunology , Humans , Molecular Sequence Data , RNA, Viral/genetics , Viral Hepatitis Vaccines/immunology , Viral Nonstructural Proteins
3.
J Virol ; 89(23): 12131-44, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26401036

ABSTRACT

UNLABELLED: Hepatitis C virus (HCV) only infects humans and chimpanzees, while GB virus B (GBV-B), another hepatotropic hepacivirus, infects small New World primates (tamarins and marmosets). In an effort to develop an immunocompetent small primate model for HCV infection to study HCV pathogenesis and vaccine approaches, we investigated the HCV life cycle step(s) that may be restricted in small primate hepatocytes. First, we found that replication-competent, genome-length chimeric HCV RNAs encoding GBV-B structural proteins in place of equivalent HCV sequences designed to allow entry into simian hepatocytes failed to induce viremia in tamarins following intrahepatic inoculation, nor did they lead to progeny virus in permissive, transfected human Huh7.5 hepatoma cells upon serial passage. This likely reflected the disruption of interactions between distantly related structural and nonstructural proteins that are essential for virion production, whereas such cross talk could be restored in similarly designed HCV intergenotypic recombinants via adaptive mutations in NS3 protease or helicase domains. Next, HCV entry into small primate hepatocytes was examined directly using HCV-pseudotyped retroviral particles (HCV-pp). HCV-pp efficiently infected tamarin hepatic cell lines and primary marmoset hepatocyte cultures through the use of the simian CD81 ortholog as a coreceptor, indicating that HCV entry is not restricted in small New World primate hepatocytes. Furthermore, we observed genomic replication and modest virus secretion following infection of primary marmoset hepatocyte cultures with a highly cell culture-adapted HCV strain. Thus, HCV can successfully complete its life cycle in primary simian hepatocytes, suggesting the possibility of adapting some HCV strains to small primate hosts. IMPORTANCE: Hepatitis C virus (HCV) is an important human pathogen that infects over 150 million individuals worldwide and leads to chronic liver disease. The lack of a small animal model for this infection impedes the development of a preventive vaccine and pathogenesis studies. In seeking to establish a small primate model for HCV, we first attempted to generate recombinants between HCV and GB virus B (GBV-B), a hepacivirus that infects small New World primates (tamarins and marmosets). This approach revealed that the genetic distance between these hepaciviruses likely prevented virus morphogenesis. We next showed that HCV pseudoparticles were able to infect tamarin or marmoset hepatocytes efficiently, demonstrating that there was no restriction in HCV entry into these simian cells. Furthermore, we found that a highly cell culture-adapted HCV strain was able to achieve a complete viral cycle in primary marmoset hepatocyte cultures, providing a promising basis for further HCV adaptation to small primate hosts.


Subject(s)
GB virus B/physiology , Hepacivirus/physiology , Life Cycle Stages/physiology , Models, Animal , Primates/virology , Virus Internalization , Animals , Base Sequence , DNA Primers/genetics , Enzyme-Linked Immunosorbent Assay , Fluorescent Antibody Technique , HEK293 Cells , Hepacivirus/genetics , Hepatocytes/virology , Host Specificity , Humans , Immunoblotting , Molecular Sequence Data , Plasmids/genetics , Sequence Analysis, DNA , Viremia
4.
J Virol ; 88(13): 7426-44, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24741107

ABSTRACT

UNLABELLED: GB virus B (GBV-B), which is hepatotropic in experimentally infected small New World primates, is a member of the Hepacivirus genus but phylogenetically relatively distant from hepatitis C virus (HCV). To gain insights into the role and specificity of hepaciviral nonstructural protein 2 (NS2), which is required for HCV polyprotein processing and particle morphogenesis, we investigated whether NS2 structural and functional features are conserved between HCV and GBV-B. We found that GBV-B NS2, like HCV NS2, has cysteine protease activity responsible for cleavage at the NS2/NS3 junction, and we experimentally confirmed the location of this junction within the viral polyprotein. A model for GBV-B NS2 membrane topology was experimentally established by determining the membrane association properties of NS2 segments fused to green fluorescent protein (GFP) and their nuclear magnetic resonance structures using synthetic peptides as well as by applying an N-glycosylation scanning approach. Similar glycosylation studies confirmed the HCV NS2 organization. Together, our data show that despite limited amino acid sequence similarity, GBV-B and HCV NS2 proteins share a membrane topology with 3 N-terminal transmembrane segments, which is also predicted to apply to other recently discovered hepaciviruses. Based on these data and using trans-complementation systems, we found that intragenotypic hybrid NS2 proteins with heterologous N-terminal membrane segments were able to efficiently trans-complement an assembly-deficient HCV mutant with a point mutation in the NS2 C-terminal domain, while GBV-B/HCV or intergenotypic NS2 chimeras were not. These studies indicate that virus- and genotype-specific intramolecular interactions between N- and C-terminal domains of NS2 are critically involved in HCV morphogenesis. IMPORTANCE: Nonstructural protein 2 (NS2) of hepatitis C virus (HCV) is a multifunctional protein critically involved in polyprotein processing and virion morphogenesis. To gain insights into NS2 mechanisms of action, we investigated whether NS2 structural and functional features are conserved between HCV and GB virus B (GBV-B), a phylogenetically relatively distant primate hepacivirus. We showed that GBV-B NS2, like HCV NS2, carries cysteine protease activity. We experimentally established a model for GBV-B NS2 membrane topology and demonstrated that despite limited sequence similarity, GBV-B and HCV NS2 share an organization with three N-terminal transmembrane segments. We found that the role of HCV NS2 in particle assembly is genotype specific and relies on critical interactions between its N- and C-terminal domains. This first comparative analysis of NS2 proteins from two hepaciviruses and our structural predictions of NS2 from other newly identified mammal hepaciviruses highlight conserved key features of the hepaciviral life cycle.


Subject(s)
Cell Membrane/metabolism , Flaviviridae Infections/metabolism , Hepatitis C/metabolism , Hepatitis, Viral, Human/metabolism , Viral Nonstructural Proteins/metabolism , Amino Acid Sequence , Flaviviridae Infections/virology , Fluorescent Antibody Technique , GB virus B/physiology , Hepacivirus/physiology , Hepatitis C/virology , Hepatitis, Viral, Human/virology , Humans , Immunoblotting , Molecular Sequence Data , Protein Conformation , Sequence Homology, Amino Acid , Viral Nonstructural Proteins/chemistry , Virus Replication
5.
Virus Res ; 179: 93-101, 2014 Jan 22.
Article in English | MEDLINE | ID: mdl-24246306

ABSTRACT

Flaviviruses related to hepatitis C virus (HCV) in suitable animal models may provide further insight into the role that cellular immunity contributes to spontaneous clearance of HCV. We characterised changes in lymphocyte populations in tamarins with an acute GBV-B infection, a hepatitis virus of the flaviviridae. Major immune cell populations were monitored in peripheral and intra-hepatic lymphocytes at high viraemia or following a period when peripheral virus was no longer detected. Limited changes in major lymphocyte populations were apparent during high viraemia; however, the proportions of CD3(+) lymphocytes decreased and CD20(+) lymphocytes increased once peripheral viraemia became undetectable. Intrahepatic lymphocyte populations increased at both time points post-infection. Distinct expression patterns of PD-1, a marker of T-cell activation, were observed on peripheral and hepatic lymphocytes; notably there was elevated PD-1 expression on hepatic CD4(+) T-cells during high viraemia, suggesting an activated phenotype, which decreased following clearance of peripheral viraemia. At times when peripheral vRNA was not detected, suggesting viral clearance, we were able to readily detect GBV-B RNA in the liver, indicative of long-term virus replication. This study is the first description of changes in lymphocyte populations during GBV-B infection of tamarins and provides a foundation for more detailed investigations of the responses that contribute to the control of GBV-B infection.


Subject(s)
Disease Models, Animal , Flaviviridae Infections/virology , GB virus B/physiology , Hepatitis, Viral, Human/virology , Liver/immunology , Saguinus , Animals , Flaviviridae Infections/immunology , GB virus B/immunology , Hepatitis, Viral, Human/immunology , Humans , Liver/virology , Lymphocyte Activation , Saguinus/immunology , Saguinus/virology , T-Lymphocytes/immunology , Viremia/immunology , Viremia/virology , Virus Replication
6.
J Virol ; 83(16): 8062-75, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19474092

ABSTRACT

Approximately 3% of the world population is chronically infected with hepatitis C virus (HCV). GB virus B (GBV-B), a surrogate model for HCV, causes hepatitis in tamarins and is the virus phylogenetically most closely related to HCV. Previously we described a chimeric GBV-B containing an HCV insert from the 5' noncoding region (NCR) that was adapted for efficient replication in tamarins (Saguinus species). We have also demonstrated that wild-type (WT) GBV-B rapidly adapts for efficient replication in a closely related species, the common marmoset (Callithrix jacchus). Here, we demonstrate that the chimeric virus failed to adapt during serial passage in marmosets. The chimeric virus was passaged four times through 24 marmosets. During passage, two marmoset phenotypes were observed: susceptible and partially resistant. Although appearing to adapt in a resistant animal during a prolonged and gradual increase in viremia, the chimeric GBV-B failed to replicate efficiently upon passage to a naïve marmoset. The resistance was specific to the chimeric virus, as the chimeric virus-resistant animals were susceptible to marmoset-adapted WT virus during rechallenge studies. Three isolates of the chimeric virus were sequenced, and 20 nucleotide changes were observed, including eight amino acid changes. Three unique changes were observed in the 5' NCR chimeric insert, an area that is highly conserved in HCV. We speculate that the failure of the chimeric virus to adapt in marmosets might be due to a bottleneck that occurs at the time of infection of resistant animals, which may lead to a loss of fitness upon serial passage.


Subject(s)
Callithrix , Disease Models, Animal , Flaviviridae Infections/virology , GB virus B/physiology , Hepacivirus/physiology , Hepatitis C/virology , Animals , Base Sequence , Female , GB virus B/chemistry , GB virus B/genetics , Hepacivirus/genetics , Humans , Male , Molecular Sequence Data , Nucleic Acid Conformation , RNA, Viral/chemistry , RNA, Viral/genetics , RNA, Viral/metabolism , Serial Passage , Virus Replication
7.
PLoS One ; 4(2): e4419, 2009.
Article in English | MEDLINE | ID: mdl-19204793

ABSTRACT

GB virus B (GBV-B) is closely related to hepatitis C virus (HCV), infects small non-human primates, and is thus a valuable surrogate for studying HCV. Despite significant differences, the 5' nontranslated RNAs (NTRs) of these viruses fold into four similar structured domains (I-IV), with domains II-III-IV comprising the viral internal ribosomal entry site (IRES). We previously reported the in vivo rescue of a chimeric GBV-B (vGB/III(HC)) containing HCV sequence in domain III, an essential segment of the IRES. We show here that three mutations identified within the vGB/III(HC) genome (within the 3'NTR, upstream of the poly(U) tract, and NS5A coding sequence) are necessary and sufficient for production of this chimeric virus following intrahepatic inoculation of synthetic RNA in tamarins, and thus apparently compensate for the presence of HCV sequence in domain III. To assess the mechanism(s) underlying these compensatory mutations, and to determine whether 5'NTR subdomains participating in genome replication do so in a virus-specific fashion, we constructed and evaluated a series of chimeric subgenomic GBV-B replicons in which various 5'NTR subdomains were substituted with their HCV homologs. Domains I and II of the GBV-B 5'NTR could not be replaced with HCV sequence, indicating that they contain essential, virus-specific RNA replication elements. In contrast, domain III could be swapped with minimal loss of genome replication capacity in cell culture. The 3'NTR and NS5A mutations required for rescue of the related chimeric virus in vivo had no effect on replication of the subgenomic GBneoD/III(HC) RNA in vitro. The data suggest that in vivo fitness of the domain III chimeric virus is dependent on a cooperative interaction between the 5'NTR, 3'NTR and NS5A at a step in the viral life cycle subsequent to genome replication, most likely during particle assembly. Such a mechanism may be common to all hepaciviruses.


Subject(s)
GB virus B/physiology , Hepacivirus/physiology , RNA, Untranslated/metabolism , RNA, Viral/metabolism , Viral Proteins/metabolism , Animals , Base Sequence , Cell Line, Tumor , GB virus B/genetics , GB virus B/pathogenicity , Genome, Viral/genetics , Hepacivirus/genetics , Hepacivirus/pathogenicity , Humans , Molecular Sequence Data , Mutation/genetics , Nucleic Acid Conformation , Protein Biosynthesis , RNA, Untranslated/chemistry , RNA, Untranslated/genetics , RNA, Viral/chemistry , RNA, Viral/genetics , Replicon , Saguinus/virology , Sequence Analysis, RNA , Virus Replication
8.
Microbiol Immunol ; 53(1): 53-7, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19161559

ABSTRACT

More than 170 million people worldwide are chronically infected by HCV, which is the causative agent of chronic hepatitis C, cirrhosis, and finally liver cancer. Although animal models of viral hepatitis are a prerequisite for the evaluation of antiviral and vaccine efficacy, the restricted host range of HCV has hampered the development of a suitable small animal model of HCV infection. Use of the chimpanzee, the only animal known to be susceptible to HCV infection, is limited by ethical and financial restrictions. In this regard GBV-B, being closely related to HCV, appears to be a promising non-human surrogate model for the study of HCV infection. This review describes the characteristic of GBV-B infection of New World monkeys, and discusses current issues concerning the GBV-B model and its future directions.


Subject(s)
Disease Models, Animal , Flaviviridae Infections/veterinary , GB virus B/physiology , Hepacivirus/physiology , Hepatitis C/virology , Hepatitis, Viral, Animal/virology , Platyrrhini , Animals , Flaviviridae Infections/immunology , Flaviviridae Infections/virology , Hepatitis C/immunology , Hepatitis, Viral, Animal/immunology , Humans
9.
Biochem Biophys Res Commun ; 361(2): 294-300, 2007 Sep 21.
Article in English | MEDLINE | ID: mdl-17655825

ABSTRACT

RNA interference (RNAi) represents a new technology which could offer potential applications for the therapeutics of human diseases. RNAi-mediated therapy has recently been shown to be effective toward infectious diseases in in vitro and rodent models, however, it remains unclear whether RNAi therapy with systemic application could be effective in primates. In this study, we examined if RNAi therapy could be effective toward infectious diseases by using a non-human primate surrogate model for hepatitis C. Administration into marmosets of cationic liposome-encapsulated siRNA (CL-siRNA) for GB virus B (GBV-B), which is most closely related to hepatitis C virus, repressed GBV-B replication in a dose-dependent manner. Especially, 5 mg/kg of the CL-siRNA completely inhibited the viral replication. Since the serum interferons (IFNs) were induced by CL-siRNA in vivo, inhibition of viral regulation by anti-GBV-B CL-siRNA may include an antiviral effect of IFN. However, contribution of induced IFN may be partial, since the control CL-siRNA which induced a stronger IFN response than GBV-B CL-siRNA could only delay the viral replication. Our results suggest the feasibility of systemic administration of CL-siRNA as an antiviral strategy.


Subject(s)
GB virus B/physiology , Hepatitis C/virology , Monkey Diseases/virology , RNA, Small Interfering/metabolism , Virus Replication/physiology , 5' Untranslated Regions/genetics , Animals , Base Sequence , Callithrix , Disease Models, Animal , GB virus B/genetics , Genes, Reporter , Interferons/blood , Liposomes , Male , Mice , Molecular Sequence Data , Nucleic Acid Conformation , RNA, Viral/chemistry , RNA, Viral/genetics
10.
Microbes Infect ; 9(4): 515-21, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17349810

ABSTRACT

GB virus B (GBV-B) infection of New World monkeys is considered to be a useful surrogate model for hepatitis C virus (HCV) infection. GBV-B replicates in the liver and induces acute resolving hepatitis but little is known whether the other organs could be permissive for the virus. We investigated the viral tropism of GBV-B in tamarins in the acute stage of viral infection and found that the viral genomic RNA could be detected in a variety of tissues. Notably, a GBV-B-infected tamarin with marked acute viremia scarcely showed a sign of hepatitis, due to preferential infection in lymphoid tissues such as lymph nodes and spleen. These results indicate that GBV-B as well as HCV is a pleiotropic virus in vivo.


Subject(s)
Flaviviridae Infections/virology , GB virus B/physiology , Hepatitis, Viral, Animal/virology , Lymph Nodes/virology , Spleen/virology , Animals , Disease Models, Animal , GB virus B/genetics , GB virus B/isolation & purification , Hepacivirus/physiology , RNA, Viral/analysis , RNA, Viral/genetics , Saguinus , Tropism/physiology
11.
Antivir Ther ; 11(3): 289-95, 2006.
Article in English | MEDLINE | ID: mdl-16759044

ABSTRACT

A chemically synthesized peptide representing the C-terminal subunit (p13-C) of the p13 protein of GB virus B (GBV-B), the most closely related virus to hepatitis C virus (HCV) showed ion channel activity in artificial lipid bilayers. The channels had a variable conductance and were more permeable to potassium ions than to chloride ions. Amantadine but not hexamethylene amiloride (HMA) inhibited the ion channel function of p13-C in the lipid membranes. However, neither agent was able to inhibit the replication and secretion of GBV-B from virus-infected cultured marmoset hepatocytes, which were harvested from a marmoset that was infected in vivo or inhibit replication after in vitro infection of naive hepatocytes. These data suggest that the GBV-B ion channel, contrary to the data derived from the lipid membranes, is either resistant to amantadine or that virus replication and secretion are independent of ion channel function. As the p7 protein of HCV also has ion channel activity that is apparently resistant to amantadine in vivo, the former possibility is most likely. Ion channels are likely to have an important role in the life cycle of many viruses and compounds that block these channels may prove to be useful antiviral agents.


Subject(s)
Amantadine/pharmacology , Antiviral Agents/pharmacology , GB virus B/drug effects , Ion Channels/drug effects , Viral Proteins/genetics , Virus Replication/drug effects , Amino Acid Sequence , Animals , Callithrix , Cells, Cultured , Flaviviridae Infections/virology , GB virus B/genetics , GB virus B/metabolism , GB virus B/physiology , Hepatitis, Viral, Animal/virology , Hepatocytes/virology , Ion Channels/chemistry , Ion Channels/genetics , Ion Channels/metabolism , Lipid Bilayers , Molecular Sequence Data , Viral Proteins/chemistry , Viral Proteins/metabolism
12.
Antiviral Res ; 66(2-3): 165-8, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15911032

ABSTRACT

GB virus B (GBV-B) is the most closely related virus to the hepatitis C virus (HCV) and is an attractive surrogate model system for HCV drug development efforts. Unfortunately, GBV-B can only be grown in the primary hepatocytes of certain non-human primates. We grew GBV-B in tamarins and marmosets and then used this virus in the absence and presence of lipofection reagents to try to infect 20 different cell lines including human primary hepatocytes and marmoset primary hepatocytes. GBV-B only replicated in marmoset primary hepatocytes. We isolated primary hepatocytes from GBV-B-positive and negative tamarins and marmosets and tried to immortalize the cells using SV40 large T-antigen or cell fusion. GBV-B stable cell lines were constructed in Huh7 and HepG2 cell lines, but there was no evidence for viral replication or a response to antiviral agents in these lines. Infectious full-length GBV-B RNA could be transfected into Vero, Huh7 and HepG2 at high efficiency, however there was no evidence for GBV-B replication or a response to antiviral agents. None of these approaches were successful and an in vitro model of GBV-B replication using immortalized cell lines was not produced. We hypothesize that these immortalized cell lines lack liver-specific factors that are required for GBV-B replication.


Subject(s)
GB virus B/physiology , Virus Replication , Animals , Cell Line , Humans
13.
J Virol ; 78(17): 9389-99, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15308733

ABSTRACT

GB virus B (GBV-B), the virus most closely related to hepatitis C virus (HCV), infects tamarins and causes acute hepatitis. The 3' untranslated region (UTR) of an infectious GBV-B clone (pGBB) has a proximal short sequence followed by a poly(U) tract and a 3' terminal sequence. Our investigators previously demonstrated that the 3' terminal sequence was critical for in vivo infectivity. Here, we tested the effect of deleting the short sequence and/or the poly(U) tract from pGBB; infectivity of each mutant was tested by intrahepatic transfection of two tamarins with transcribed RNA. A mutant lacking both regions was not viable. However, mutants lacking either the short sequence or the poly(U) tract were viable. All four tamarins had a wild-type-like acute infection and developed acute hepatitis. Whereas we found that five tamarins transfected with the wild-type clone pGBB had acute resolving infection, one tamarin transfected with the poly(U) deletion mutant became persistently infected. This animal had viremia and hepatitis until its death at week 90. The genomes recovered at weeks 2, 7, 15, 20, 60, and 90 lacked the poly(U) stretch. Eight amino acid changes were identified at week 90. One change, in the putative p7 protein, was dominant at week 15. Thus, persistence of GBV-B, like persistence of HCV, was associated with the emergence of virus variants. Four tamarins inoculated with serum collected at weeks 2 and 90 from the tamarin with persistent infection had an acute resolving infection. Nonetheless, the demonstration that GBV-B can persist in tamarins strengthens its relevance as a surrogate model for the study of HCV.


Subject(s)
3' Untranslated Regions/genetics , GB virus B/genetics , GB virus B/physiology , Genetic Engineering , Mutagenesis/genetics , Saguinus/virology , Animals , Base Sequence , Cloning, Molecular , DNA, Complementary/genetics , Flaviviridae Infections/virology , GB virus B/pathogenicity , Genome, Viral , Green Fluorescent Proteins , Hepatitis, Viral, Animal/virology , Luminescent Proteins/genetics , Molecular Sequence Data , Poly U/genetics , Polyproteins/genetics , Sequence Deletion/genetics , Time Factors , Transfection , Virus Replication
14.
J Virol ; 77(22): 11875-81, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14581524

ABSTRACT

Hepatitis C virus (HCV) and GB virus B (GBV-B) replicons have been reported to replicate only in Huh7 cells. Here we demonstrate that subpopulations of another human hepatoma cell line, Hep3B, are permissive for the GBV-B replicon, showing different levels of enhancement of replication from those of the unselected parental cell population. Adaptive mutations are not required for replication of the GBV-B replicon in these cells, as already demonstrated for Huh7 cells. Nonetheless, we identified a mutant replicon in one of the selected cell lines, which, although lacking the 5' end proximal stem-loop, is able to replicate in Hep3B cells as well as in Huh7 cells. This mutant indeed shows a higher replication efficiency than does wild-type replicon, especially in the Hep3B cell clone from which it was originally recovered. This indicates that the stem-loop Ia is not necessary for replication of the GBV-B replicon in human cells, unlike what occurs with HCV, and that its absence can even provide a selective advantage.


Subject(s)
Carcinoma, Hepatocellular/virology , GB virus B/physiology , Liver Neoplasms/virology , Replicon , Virus Replication , 5' Untranslated Regions/chemistry , Cell Line, Tumor , GB virus B/genetics , Humans , Mutation , Protein Biosynthesis , RNA, Viral/chemistry
15.
J Virol ; 77(13): 7502-9, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12805450

ABSTRACT

The yield of G418-resistant Huh7 cell clones bearing subgenomic dicistronic GB virus B (GBV-B) is significantly affected by the insertion of a portion of the viral core gene between the GBV-B 5' untranslated region and the exogenous neomycin phosphotransferase selector gene (A. De Tomassi, M. Pizzuti, R. Graziani, A. Sbardellati, S. Altamura, G. Paonessa, and C. Traboni, J. Virol. 76:7736-7746, 2002). In this report, we have dissected this phenomenon, examining the effects of the insertion of core sequences of different lengths on GBV-B IRES-dependent translation and RNA replication by using experimental approaches aimed at analyzing these two aspects independently. The results achieved indicate that an enhancement of translation efficiency does occur and that it correlates with the length of the inserted core sequences. Interestingly, the insertion of these sequences also has a direct similar effect on the efficiency of replication of the GBV-B replicon. These results suggest that in GBV-B replicon RNA and potentially in the complete viral genome, the core coding sequences not only are part of the IRES but also take part in the replication process, independently of the presence of the corresponding whole protein.


Subject(s)
GB virus B/genetics , Protein Biosynthesis/genetics , Virus Replication/genetics , 5' Untranslated Regions , Amino Acid Sequence , Base Sequence , DNA, Viral , GB virus B/physiology , Humans , Molecular Sequence Data , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...